$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921012546 Filed on May 17, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$1.889M	$522.5K
YoY Change	261.47%	-5.28%
Cost Of Revenue	$766.6K	$124.3K
YoY Change	516.95%	-79.43%
Gross Profit	$1.122M	$398.2K
YoY Change	181.75%	-859.57%
Gross Profit Margin	59.41%	76.22%
Selling, General & Admin	$1.516M	$1.381M
YoY Change	9.77%	0.32%
% of Gross Profit	135.15%	346.89%
Research & Development	$441.7K	$336.9K
YoY Change	31.1%	-9.95%
% of Gross Profit	39.36%	84.6%
Depreciation & Amortization	$25.12K	$19.91K
YoY Change	26.13%	3.21%
% of Gross Profit	2.24%	5.0%
Operating Expenses	$1.958M	$1.718M
YoY Change	13.95%	-1.88%
Operating Profit	-$836.0K	-$2.050M
YoY Change	-59.22%	-2928980.0%
Interest Expense	$18.00K	$1.551M
YoY Change	-98.84%
% of Operating Profit
Other Income/Expense, Net	-$15.39K	-$1.320M
YoY Change	-98.83%	-26.81%
Pretax Income	-$850.0K	-$3.370M
YoY Change	-74.78%	87.22%
Income Tax
% Of Pretax Income
Net Earnings	-$851.4K	-$3.370M
YoY Change	-74.74%	86.87%
Net Earnings / Revenue	-45.08%	-645.05%
Basic Earnings Per Share	-$0.11
Diluted Earnings Per Share	-$109.4K	-$1.774M
COMMON SHARES
Basic Shares Outstanding	7.774M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.04M	$1.170M
YoY Change	1100.0%	154.35%
Cash & Equivalents	$13.53M	$661.9K
Short-Term Investments	$510.0K	$510.0K
Other Short-Term Assets	$49.81K	$130.7K
YoY Change	-61.88%	72.33%
Inventory	$600.4K	$388.9K
Prepaid Expenses
Receivables	$970.6K	$120.3K
Other Receivables	$50.00K	$130.0K
Total Short-Term Assets	$17.73M	$1.990M
YoY Change	790.95%	-44.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.99K	$75.60K
YoY Change	-7.42%	-50.5%
Goodwill	$1.263M
YoY Change
Intangibles	$1.460M	$147.2K
YoY Change	891.79%	-24.24%
Long-Term Investments
YoY Change
Other Assets	$180.0K	$220.0K
YoY Change	-18.18%	-29.03%
Total Long-Term Assets	$3.753M	$1.029M
YoY Change	264.64%	-86.64%
TOTAL ASSETS
Total Short-Term Assets	$17.73M	$1.990M
Total Long-Term Assets	$3.753M	$1.029M
Total Assets	$21.48M	$3.019M
YoY Change	611.53%	-75.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$309.3K	$617.0K
YoY Change	-49.87%	30.54%
Accrued Expenses	$536.0K	$515.1K
YoY Change	4.05%	-10.88%
Deferred Revenue	$524.8K	$413.3K
YoY Change	26.97%	24.04%
Short-Term Debt		$2.370M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.600M	$4.077M
YoY Change	-60.75%	146.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$260.0K	$350.0K
YoY Change	-25.71%	-16.67%
Total Long-Term Liabilities	$260.8K	$353.6K
YoY Change	-26.22%	-15.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.600M	$4.077M
Total Long-Term Liabilities	$260.8K	$353.6K
Total Liabilities	$1.861M	$4.430M
YoY Change	-57.99%	143.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$100.4M	-$93.21M
YoY Change	7.68%	21.14%
Common Stock	$782.00	$1.839K
YoY Change	-57.48%	31.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.62M	-$1.411M
YoY Change
Total Liabilities & Shareholders Equity	$21.48M	$3.019M
YoY Change	611.53%	-75.42%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$851.4K	-$3.370M
YoY Change	-74.74%	86.87%
Depreciation, Depletion And Amortization	$25.12K	$19.91K
YoY Change	26.13%	3.21%
Cash From Operating Activities	-$3.199M	-$1.023M
YoY Change	212.72%	-737.28%
INVESTING ACTIVITIES
Capital Expenditures	$13.31K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$13.31K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$252.7K	1.606M
YoY Change	-115.74%
NET CHANGE
Cash From Operating Activities	-$3.199M	-1.023M
Cash From Investing Activities	-$13.31K
Cash From Financing Activities	-$252.7K	1.606M
Net Change In Cash	-$3.465M	582.9K
YoY Change	-694.34%	330.62%
FREE CASH FLOW
Cash From Operating Activities	-$3.199M	-$1.023M
Capital Expenditures	$13.31K
Free Cash Flow	-$3.212M	-$1.023M
YoY Change	214.03%	-846.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q1	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	2709
CY2021Q1	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature
CY2020Q1	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	413687
CY2021Q1	bkyi	Beneficial Conversion Feature BeneficialConversionFeature
CY2020Q1	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	641215
CY2021Q1	bkyi	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	0
CY2020Q1	bkyi	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	0
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662
CY2020Q1	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-900000
CY2021Q1	bkyi	Common Stock Issued For Loan Commitment Fees CommonStockIssuedForLoanCommitmentFees
CY2020Q1	bkyi	Common Stock Issued For Loan Commitment Fees CommonStockIssuedForLoanCommitmentFees	132500
CY2020Q1	bkyi	Deemed Dividend Related To Down Round Features DeemedDividendRelatedToDownRoundFeatures
CY2021Q1	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	51622
CY2020Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	181262
CY2021Q1	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	101430
CY2020Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	241715
CY2021Q1	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2021Q1	bkyi	Factoring Fees FactoringFees	13347
CY2020Q1	bkyi	Factoring Fees FactoringFees	32000
CY2021Q1	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	27893
CY2020Q1	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	13659
CY2021Q1	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-56958
CY2020Q1	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-44587
CY2021Q1	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-2521
CY2020Q1	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-5028
CY2021Q1	bkyi	Monthly Cash Requirement To Conduct Operations And Pay Dividend Obligations MonthlyCashRequirementToConductOperationsAndPayDividendObligations	735000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330
CY2021Q1	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18
CY2021Q1	bkyi	Prepaid Deposit For Hardware Devices PrepaidDepositForHardwareDevices	1400000
CY2021Q1	bkyi	Prepaid Deposit For Inventory PrepaidDepositForInventory	1423445
CY2020Q4	bkyi	Prepaid Deposit For Inventory PrepaidDepositForInventory	66995
CY2021Q1	bkyi	Prepaid Software License PrepaidSoftwareLicense	26410
CY2020Q4	bkyi	Prepaid Software License PrepaidSoftwareLicense	24866
CY2021Q1	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	133638
CY2020Q1	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	512719
CY2021Q1	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	56361
CY2020Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	58882
CY2021Q1	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	7510
CY2020Q1	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	33334
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	14368
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	17071
CY2020Q1	bkyi	Stock Issued During Period Shares Warrants Exercises StockIssuedDuringPeriodSharesWarrantsExercises	121500
CY2020Q1	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	1458000
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	133333
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	100000
CY2020Q3	bkyi	Stock Returned During The Period Shares Commitment Fee StockReturnedDuringThePeriodSharesCommitmentFee	75000
CY2021Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	49808
CY2020Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	60453
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	309323
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	244158
CY2021Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1446033
CY2020Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	561834
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1432248
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	548049
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1432248
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	548049
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	535952
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	508487
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119982465
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119844026
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	641215
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	133638
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	512719
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	141148
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	512719
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13785
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13785
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18000
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	218061
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	878398
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54016
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7164
CY2021Q1	us-gaap	Assets Assets	21483145
CY2020Q4	us-gaap	Assets Assets	22520572
CY2021Q1	us-gaap	Assets Current AssetsCurrent	17730006
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18941873
CY2021Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	3753139
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3578699
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	22989
CY2020Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	36679
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13528521
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16993096
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16993096
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79013
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13528521
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	661937
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3464575
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	582924
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	12
CY2015Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	28.80
CY2015Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8681
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7817913
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7814572
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7817913
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7814572
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	782
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	782
CY2021Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	170219
CY2020Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	165315
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	574000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	702000
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	524836
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	657349
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	49393
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	44987
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	305000
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	72000
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	766635
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	124263
CY2021Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2021Q1	us-gaap	Depreciation Depreciation	25115
CY2020Q1	us-gaap	Depreciation Depreciation	19912
CY2015Q3	us-gaap	Dividends Paidinkind DividendsPaidinkind	41688
CY2021Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.84
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076
CY2021Q1	us-gaap	Goodwill Goodwill	1262526
CY2020Q4	us-gaap	Goodwill Goodwill	1262526
CY2021Q1	us-gaap	Gross Profit GrossProfit	1122003
CY2020Q1	us-gaap	Gross Profit GrossProfit	398222
CY2021Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2020Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	65165
CY2020Q4	us-gaap	Inventory Net InventoryNet	330947
CY2021Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	106125
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	109817
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2615
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-227572
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	884199
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5707
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27465
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-57777
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-128107
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	54133
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	269500
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-31408
CY2021Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10645
CY2020Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19729
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1404654
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58175
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1460130
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1514146
CY2021Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized
CY2020Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	40995
CY2021Q1	us-gaap	Interest Expense InterestExpense	18000
CY2020Q1	us-gaap	Interest Expense InterestExpense	1551141
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	18000
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	494322
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	221130
CY2021Q1	us-gaap	Inventory Net InventoryNet	600447
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3370282
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-851431
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3482968
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	89225
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	193165
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	28470
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1
CY2021Q1	us-gaap	Lease Cost LeaseCost	63973
CY2020Q1	us-gaap	Lease Cost LeaseCost	53723
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	469984
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	187594
CY2021Q1	us-gaap	Liabilities Liabilities	1861018
CY2020Q4	us-gaap	Liabilities Liabilities	2185453
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21483145
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22520572
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1600183
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1876303
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	260835
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	309150
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24000000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-252709
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1605729
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13307
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3198559
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1022805
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-851431
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	46009
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y14D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y94D
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-836046
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1320066
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000
CY2021Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000
CY2021Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	295000
CY2020Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1958049
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	1718288
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15385
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2050216
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	63973
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	53723
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	441514
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	498472
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	230072
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	234309
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	211442
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	264163
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	63812
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	52301
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	430206
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487325
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	57119
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	49808
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	60453
CY2021Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	109371
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	64178
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2709
CY2020Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	13000
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13307
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1606161
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	201507
CY2021Q1	us-gaap	Prepaid Insurance PrepaidInsurance	46935
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	45468
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt
CY2020Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	283000
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	69985
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	81793
CY2021Q1	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.05
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000
CY2020Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2021Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	122271
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	441651
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	336889
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100361120
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99509689
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1888638
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	522485
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1516398
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1381399
CY2020Q1	us-gaap	Share Price SharePrice	6.08
CY2020Q2	us-gaap	Share Price SharePrice	5.20
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	9.28
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.86
CY2021Q1	us-gaap	Short Term Borrowings ShortTermBorrowings
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	232000
CY2021Q1	us-gaap	Stock Issued1 StockIssued1
CY2020Q1	us-gaap	Stock Issued1 StockIssued1	1500000
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1500000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1032500
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7510
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19622127
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	20335119
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-1411021
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7773688
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1895690

Files In Submission

Name	View Source	Status
0001437749-21-012546-index-headers.html	Edgar Link	pending
0001437749-21-012546-index.html	Edgar Link	pending
0001437749-21-012546.txt	Edgar Link	pending
0001437749-21-012546-xbrl.zip	Edgar Link	pending
bkyi-20210331.xml	Edgar Link	completed
bkyi-20210331.xsd	Edgar Link	pending
bkyi-20210331_cal.xml	Edgar Link	unprocessable
bkyi-20210331_def.xml	Edgar Link	unprocessable
bkyi-20210331_lab.xml	Edgar Link	unprocessable
bkyi-20210331_pre.xml	Edgar Link	unprocessable
bkyi20210331_10q.htm	Edgar Link	pending
ex_248887.htm	Edgar Link	pending
ex_248893.htm	Edgar Link	pending
ex_248894.htm	Edgar Link	pending
ex_248911.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2021 Q1 Form 10-Q Financial Statement

#000143774921012546 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2021 Q1 Form 10-Q Financial Statement

#000143774921012546 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi